Dores Artemisa R, Carvalho Irene P, Burkauskas Julius, Simonato Pierluigi, De Luca Ilaria, Mooney Roisin, Ioannidis Konstantinos, Gómez-Martínez M Ángeles, Demetrovics Zsolt, Ábel Krisztina Edina, Szabo Attila, Fujiwara Hironobu, Shibata Mami, Ventola Alejandra Rebeca Melero, Arroyo-Anlló Eva Maria, Santos-Labrador Ricardo M, Griskova-Bulanova Inga, Pranckeviciene Aiste, Kobayashi Kei, Martinotti Giovanni, Fineberg Naomi A, Barbosa Fernando, Corazza Ornella
Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, Porto, Portugal.
School of Health, Polytechnic of Porto, Porto, Portugal.
Front Psychiatry. 2021 Mar 10;12:648501. doi: 10.3389/fpsyt.2021.648501. eCollection 2021.
Little is known about the impact of restrictive measures during the COVID-19 pandemic on self-image and engagement in exercise and other coping strategies alongside the use of image and performance-enhancing drugs (IPEDs) to boost performance and appearance. To assess the role of anxiety about appearance and self-compassion on the practice of physical exercise and use of IPEDs during lockdown. An international online questionnaire was carried out using the Exercise Addiction Inventory (EAI), the Appearance Anxiety Inventory (AAI), and the Self-Compassion Scale (SCS) in addition to questions on the use of IPEDs. The sample consisted of 3,161 (65% female) adults from Italy (41.1%), Spain (15.7%), the United Kingdom (UK) (12.0%), Lithuania (11.6%), Portugal (10.5%), Japan (5.5%), and Hungary (3.5%). The mean age was 35.05 years ( = 12.10). Overall, 4.3% of the participants were found to engage in excessive or problematic exercise with peaks registered in the UK (11.0%) and Spain (5.4%). The sample reported the use of a wide range of drugs and medicines to boost image and performance (28%) and maintained use during the lockdown, mostly in Hungary (56.6%), Japan (46.8%), and the UK (33.8%), with 6.4% who started to use a new drug. Significant appearance anxiety levels were found across the sample, with 18.1% in Italy, 16.9% in Japan, and 16.7% in Portugal. Logistic regression models revealed a strong association between physical exercise and IPED use. Anxiety about appearance also significantly increased the probability of using IPEDs. However, self-compassion did not significantly predict such behavior. Anxiety about appearance and self-compassion were non-significant predictors associated with engaging in physical exercise. This study identified risks of problematic exercising and appearance anxiety among the general population during the COVID-19 lockdown period across all the participating countries with significant gender differences. Such behaviors were positively associated with the unsupervised use of IPEDs, although no interaction between physical exercise and appearance anxiety was observed. Further considerations are needed to explore the impact of socially restrictive measures among vulnerable groups, and the implementation of more targeted responses.
关于新冠疫情期间的限制措施对自我形象、锻炼参与度以及其他应对策略的影响,以及使用形象和性能增强药物(IPEDs)来提升表现和外貌的情况,我们所知甚少。为了评估外貌焦虑和自我同情在封锁期间体育锻炼实践和IPEDs使用中的作用。除了关于IPEDs使用的问题外,还使用运动成瘾量表(EAI)、外貌焦虑量表(AAI)和自我同情量表(SCS)进行了一项国际在线问卷调查。样本包括来自意大利(41.1%)、西班牙(15.7%)、英国(12.0%)、立陶宛(11.6%)、葡萄牙(10.5%)、日本(5.5%)和匈牙利(3.5%)的3161名成年人(65%为女性)。平均年龄为35.05岁(标准差 = 12.10)。总体而言,4.3%的参与者被发现存在过度或有问题的锻炼行为,其中英国(11.0%)和西班牙(5.4%)的比例最高。样本报告使用了多种药物和药品来提升形象和表现(28%),并且在封锁期间仍继续使用,主要集中在匈牙利(56.6%)、日本(46.8%)和英国(33.8%),有6.4%的人开始使用新的药物。整个样本中都发现了显著的外貌焦虑水平,意大利为18.1%,日本为16.9%,葡萄牙为16.7%。逻辑回归模型显示体育锻炼与IPEDs使用之间存在很强的关联。外貌焦虑也显著增加了使用IPEDs的可能性。然而,自我同情并未显著预测这种行为。外貌焦虑和自我同情与参与体育锻炼之间没有显著的预测关系。这项研究确定了在新冠疫情封锁期间,所有参与国家的普通人群中存在有问题的锻炼和外貌焦虑风险,且存在显著的性别差异。这些行为与无监督使用IPEDs呈正相关,尽管未观察到体育锻炼与外貌焦虑之间的相互作用。需要进一步考虑探讨社会限制措施对弱势群体的影响,以及实施更有针对性的应对措施。